Mario A Ostrowski
Overview
Explore the profile of Mario A Ostrowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
3210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu J, Wang L, Kurtesi A, Budylowski P, Potts K, Menon H, et al.
NPJ Vaccines
. 2025 Jan;
10(1):4.
PMID: 39788981
Continuously emerging SARS-CoV-2 Omicron subvariants pose a threat thwarting the effectiveness of approved COVID-19 vaccines. Especially, the protection breadth and degree of these vaccines against antigenically distant Omicron subvariants is...
2.
Huang Y, Zhu C, Kondo Y, Anderson A, Gandhi A, Russell A, et al.
Nature
. 2024 Feb;
626(8001):E19.
PMID: 38336833
No abstract available.
3.
Nantel S, Sheikh-Mohamed S, Chao G, Kurtesi A, Hu Q, Wood H, et al.
Mucosal Immunol
. 2024 Jan;
17(2):201-210.
PMID: 38278415
Our understanding of the quality of cellular and humoral immunity conferred by COVID-19 vaccination alone versus vaccination plus SARS-CoV-2 breakthrough (BT) infection remains incomplete. While the current (2023) SARS-CoV-2 immune...
4.
Reyes-Gopar H, Marston J, Singh B, Greenig M, Lin J, Ostrowski M, et al.
bioRxiv
. 2024 Jan;
PMID: 38234829
Single cell RNA sequencing (scRNA-seq) is revolutionizing the study of complex biological systems. However, most sequencing studies overlook the contribution of transposable element (TE) expression to the transcriptome. In both...
5.
Liu J, Budylowski P, Samson R, Griffin B, Babuadze G, Rathod B, et al.
Sci Adv
. 2022 Jan;
8(3):eabj9815.
PMID: 35044832
Safe and effective vaccines are needed to end the COVID-19 pandemic. Here, we report the preclinical development of a lipid nanoparticle–formulated SARS-CoV-2 mRNA vaccine, PTX-COVID19-B. PTX-COVID19-B was chosen among three...
6.
Law J, Girard M, Chao G, Ward L, Isho B, Rathod B, et al.
J Immunol
. 2021 Dec;
208(2):429-443.
PMID: 34903642
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces T cell, B cell, and Ab responses that are detected for several months in recovered individuals. Whether this response resembles a typical...
7.
Kinloch N, Ren Y, Conce Alberto W, Dong W, Khadka P, Huang S, et al.
Nat Commun
. 2021 May;
12(1):2958.
PMID: 33986282
No abstract available.
8.
Kinloch N, Ren Y, Conce Alberto W, Dong W, Khadka P, Huang S, et al.
Nat Commun
. 2021 Jan;
12(1):165.
PMID: 33420062
The Intact Proviral DNA Assay (IPDA) was developed to address the critical need for a scalable method for intact HIV-1 reservoir quantification. This droplet digital PCR-based assay simultaneously targets two...
9.
Law J, Koh W, Budylowski P, Lin J, Yue F, Abe K, et al.
J Immunol
. 2020 Nov;
206(1):37-50.
PMID: 33208459
There is a pressing need for an in-depth understanding of immunity to SARS-CoV-2. In this study, we investigated human T cell recall responses to fully glycosylated spike trimer, recombinant N...
10.
Wong R, Lingwood C, Ostrowski M, Cabral T, Cochrane A
Sci Rep
. 2019 Dec;
9(1):18656.
PMID: 31796843
An amendment to this paper has been published and can be accessed via a link at the top of the paper.